Log in to save to my catalogue

Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic...

Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fbd7085924c8484b8098aba04479277d

Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis

About this item

Full title

Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis

Publisher

London: BMJ Publishing Group Ltd

Journal title

BMJ open gastroenterology, 2021-10, Vol.8 (1), p.e000774

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

BackgroundDuring COVID-19 pandemic, the safety of medical therapies for inflammatory bowel disease (IBD) in relation to COVID-19 has emerged as an area of concern. This study aimed to evaluate the association between IBD therapies and severe COVID-19 outcomes.MethodWe performed a systematic review and meta-analysis of all published studies from Dec...

Alternative Titles

Full title

Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_fbd7085924c8484b8098aba04479277d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fbd7085924c8484b8098aba04479277d

Other Identifiers

ISSN

2054-4774

E-ISSN

2054-4774

DOI

10.1136/bmjgast-2021-000774

How to access this item